Brind.

Metagenomi developed the CAST technology and presented abstracts in New Orleans, coinciding with reports that Trump-era tariffs are benefiting AI stocks.

2 reports, 1 independent Updated Jul 29
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Metagenomi developed the CAST technology and presented abstracts in New Orleans, coinciding with reports that Trump-era tariffs are benefiting AI stocks.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Insider MonkeyMetagenomi (MGX) Presents Latest in Gene Editing Technologies Metagenomi, Inc. (NASDAQ:MGX) is one of the 11 Best New Penny Stocks to Buy Right Now. On May 14, Metagenomi, Inc. (NASDAQ:MGX) announced
  • Insider MonkeyMetagenomi Showcases Advanced AI-Enhanced Gene Editing for Neurological Disorders at ASGCT Meeting Metagenomi Inc. (NASDAQ:MGX) is one of the best young stocks to buy and hold for 5 years. In mid-May